BioCorRx Inc
OTC:BICX
BioCorRx Inc
Cash from Financing Activities
BioCorRx Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BioCorRx Inc
OTC:BICX
|
Cash from Financing Activities
$1.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
4%
|
CAGR 10-Years
19%
|
|
Universal Health Services Inc
NYSE:UHS
|
Cash from Financing Activities
-$597m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
Encompass Health Corp
NYSE:EHC
|
Cash from Financing Activities
-$179.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
|
Tenet Healthcare Corp
NYSE:THC
|
Cash from Financing Activities
-$3.4B
|
CAGR 3-Years
-67%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
HCA Healthcare Inc
NYSE:HCA
|
Cash from Financing Activities
-$4.6B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-20%
|
|
Ensign Group Inc
NASDAQ:ENSG
|
Cash from Financing Activities
$2.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-26%
|
See Also
What is BioCorRx Inc's Cash from Financing Activities?
Cash from Financing Activities
1.9m
USD
Based on the financial report for Jun 30, 2023, BioCorRx Inc's Cash from Financing Activities amounts to 1.9m USD.
What is BioCorRx Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
19%
Over the last year, the Cash from Financing Activities growth was -4%.